Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-11

Clinical Trial Update: CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing carbetocin to rectal misoprostol for management of the third stage of labor in low-risk postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • rectal misoprostol (misoprostol)

Snippet

Sponsor: Cairo University | Conditions: Postpartum Hemorrhage | Phase 4 | Status: COMPLETED